about
Gene therapy for primary immune deficiencies: a Canadian perspective.Efficacy of lentiviral mediated gene therapy in an Omenn syndrome Rag2 mouse model is not hindered by inflammation and immune dysregulation.Latin American challenges with the diagnosis and treatment of primary immunodeficiency diseases.X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Advances of gene therapy for primary immunodeficiencies
@ast
Advances of gene therapy for primary immunodeficiencies
@en
Advances of gene therapy for primary immunodeficiencies
@nl
type
label
Advances of gene therapy for primary immunodeficiencies
@ast
Advances of gene therapy for primary immunodeficiencies
@en
Advances of gene therapy for primary immunodeficiencies
@nl
prefLabel
Advances of gene therapy for primary immunodeficiencies
@ast
Advances of gene therapy for primary immunodeficiencies
@en
Advances of gene therapy for primary immunodeficiencies
@nl
P2860
P1433
P1476
Advances of gene therapy for primary immunodeficiencies
@en
P2093
Fabio Candotti
P2860
P356
10.12688/F1000RESEARCH.7512.1
P407
P577
2016-03-09T00:00:00Z